UMI3 Ltd showcases innovations to Catapult Ventures

Investors meet University of Manchester academic entrepreneurs On 3rd October UMI3 Ltd held an investor day with Catapult Ventures, who manage the Greater Manchester & Cheshire Life Sciences Fund, to hear from the CEOs of two of their portfol...

Clin-e-cal announces investment from Catapult Ventures to advance its pipeline of innovative digital health respiratory applications

Alderley Park, UK – 3rd October 2018. Clin-e-cal, an innovative digital health company, today announced the completion of a new funding round to expand its development of a fundamentally new approach to training and compliance in respir...

Cytox expands collaboration with AIBL to identify those most at risk to rapidly progress to Alzheimer’s

Oxford & Manchester, UK. Cytox, a precision medicine company which today is commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s and other neurological diseases, has announced...

NPIF - Maven Equity Finance and Catapult Ventures, alongside new Manchester Tech Trust angel group, invest £700,000 in Biorelate

Manchester-based technology platform creates innovative solution for data curation in biomedicine NPIF - Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the Northern Powerhouse Investment Fund, has invest...

GM&C Life Sciences Fund announces 25th investment

Investment in digital healthcare company Rinicare is milestone deal for Fund Alderley Park, UK, 13th September 2018 – The GM&C Life Sciences Fund, managed by Catapult Ventures, has announced its 25th investment by completing the fundin...

From our portfolio

Nexus Labs

Healthcare Technology

viewview our portfolio

Our Team

Hamish Graham

view complete team

Contact us

Alderley Park
Alderley Edge
SK10 4TG

Tel: 01625 344300